Skip to main content
. 2020 Feb 28;22(9):1388–1398. doi: 10.1093/neuonc/noaa044

Table 1.

Patient characteristics (N = 34)

Age, y, mean ± SD (range) 48.7 ± 16.9 (21–80)
Sex, n
Female 14
Male 20
Tumor histology, n
Oligodendroglioma 8
Diffuse astrocytoma 5
Anaplastic oligodendroglioma 1
Anaplastic astrocytoma 5
Glioblastoma 15
WHO grade, n
II 13
III 6
IV 15
IDH1/2 mutation status, n
Wildtype 20
Mutated 14
MOCA (mean ± SD, n = 14) 22.1 ± 5.76
Overall survival, mo, range, n = 8 7–17